Hansel Rayner
Endocrinology, Diabetes & Metabolism · McDonough, GANPI 1972761732
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 448 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,718 and has fallen 91.2% since, to $326 in 2025.
Across 448 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$2K
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Corcept Therapeutics$724
- Bayer$680
- Amgen$330
- plus $4K from 33 others
What the payments were for
- Food & beverage$9,227100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 70 | $1,571 |
| Novo Nordisk | 65 | $1,321 |
| Lilly USA, LLC | 59 | $1,100 |
| Corcept Therapeutics | 27 | $724 |
| Bayer | 34 | $680 |
| Amgen | 24 | $330 |
| AstraZeneca(2 entities) | 13 | $304 |
| Radius Health, Inc. | 17 | $281 |
| Boehringer Ingelheim | 14 | $274 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $220 |
| Sanofi-aventis U.S. LLC | 6 | $204 |
| BETA Bionics, Inc. | 3 | $192 |
| Medtronic | 5 | $184 |
| AbbVie | 11 | $175 |
| Novartis | 10 | $171 |
| Abbott | 9 | $167 |
| Mannkind Corporation | 8 | $142 |
| Tandem Diabetes Care, Inc. | 4 | $117 |
| Amarin Pharma, Inc. | 6 | $101 |
| Dexcom, Inc. | 5 | $100 |
| Cequr Corporation | 2 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Antares Pharma, Inc. | 4 | $71 |
| Amneal Pharmaceuticals LLC | 3 | $70 |
| Insulet Corporation | 3 | $69 |
| Astellas Pharma US Inc | 3 | $64 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Recordati_rare_diseases_inc. | 2 | $41 |
| GSK | 2 | $40 |
| Lifescan, Inc. | 2 | $39 |
| IBSA Pharma Inc. | 2 | $32 |
| Ascendis Pharma Endocrinology Inc | 1 | $30 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$440
- RECORLEV$146
- FARXIGA$125
- Ozempic$125
- GVOKE PFS$124
- MINIMED 780G$111
- Saxenda$105
- Wegovy$100
How this compares
$9,247 in reported general payments places this provider in the 80th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
See all endocrinology, diabetes & metabolism providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RecorlevLevoketoconazole | 79 | $2,379,346 |
| OzempicSemaglutide | 310 | $488,016 |
| JardianceEmpagliflozin | 271 | $370,507 |
| TrulicityDulaglutide | 193 | $360,077 |
| FarxigaDapagliflozin Propanediol | 267 | $304,415 |
| KerendiaFinerenone | 204 | $295,342 |
| Gvoke Hypopen 2-PackGlucagon | 230 | $149,899 |
| RybelsusSemaglutide | 69 | $142,297 |
| Somatuline DepotLanreotide Acetate | 12 | $100,215 |
| MounjaroTirzepatide | 51 | $81,756 |
| Tresiba Flextouch U-200Insulin Degludec | 50 | $64,016 |
| Tresiba Flextouch U-100Insulin Degludec | 50 | $47,647 |
| TymlosAbaloparatide | 14 | $41,703 |
| Novolog FlexpenInsulin Aspart | 86 | $31,828 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 29 | $31,073 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Xeris Pharmaceuticals, Inc.Recorlev | $1,571 | $2,379,34679 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $1,321 | $655,042420 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $1,100 | $454,237292 claims |
| Boehringer IngelheimJardiance | $274 | $370,507271 claims |
| AstraZenecaFarxiga | $304 | $304,415267 claims |
| BayerKerendia | $680 | $295,342204 claims |
| Radius Health, Inc.Tymlos | $281 | $41,70314 claims |
| MerckJanuvia | $13 | $24,77231 claims |
| Sanofi-aventis U.S. LLCLantus | $204 | $4,96923 claims |
| AbbVieSynthroid | $175 | $3,95650 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $70 | $2,975286 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
Other endocrinology, diabetes & metabolism in McDonough
- Bruce BodeAtlanta$1.5M
- David RobertsonAtlanta$1.4M
- Adeniyi OdugbesanLawrenceville$636K
- Miguel MunozMarietta$476K
- Jason BernerJasper$457K
- Dawn Smiley-ByrdTaylorsville$385K
- Barry JohnsMacon$335K
- Jonathan OwnbyAtlanta$291K
- Ismary DecastroSavannah$169K
- Naland ShenoySnellville$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.